- Global Pharma News & Resources

Breakpoint Therapeutics

Research & Development

Breakpoint Therapeutics is a newly founded company that will discover and develop new anti-cancer drugs. By targeting the DNA damage response (“DDR”) in cancer cells, Breakpoint Therapeutics aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways.